Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-686-1 | CAS number: 109-60-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates β in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Neurotoxicity
Administrative data
Description of key information
Propyl acetate
Rat, inhalation, motoneuronal EC37: ca. 27.5 mg/L (Frantik et al. 1994)
Mouse, inhalation, motoneuronal EC30: ca. 26 mg/L (Frantik et al. 1994)
Analogous substances
Butyl acetate
Rat, inhalation, NOAEL neurotoxicity: 14.10 mg/L (David et al. 1998)
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Effect on neurotoxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Effect on neurotoxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Propyl acetate
Groups of 4 male albino SPF-Wistar rats or 4 female H strain mice were exposed individually for 4 hours to a range of propyl acetate concentrations (analytically determined; Frantik et al. 1994). Measurement of any potential neurotoxic effect started within one minute after removal from exposure. A short electrical impulse (0.2 sec, 50 Hz, 180 V) was applied through ear electrodes. The duration of tonic extension of the hindlimbs in exposed and control rats was measured. All animals were given three control tests at weekly intervals prior to the first exposure. The concentration which resulted in a 37% (EC37) decrease in rat hindlimb extension during electrically-induced seizure events was 6600 ppm (+/- 1200 ppm) or 27.522 mg/L (+/- 5.004 mg/L), while the concentration which resulted in a 30% (EC30) decrease in mouse hindlimb extension during electrically-induced seizure events was 6200 ppm (+/- 830 ppm) or 25.854 mg/L (+/- 3.461 mg/L)
Analogous substance:
Butyl acetate
The study consisted of two sets of animals, male and female ad libitum fed Sprague-Dawley (SD) rats designated for functional observational battery, motor activity, and neuropathology endpoints (FOB/MA/NP) and male (SD) rats restricted to 12-14 g of feed per day and which were designated for schedule-controlled operant behavior (SCOB; David et al. 1998). Animals were distributed into four groups of 30 animals each. Ten males and 10 females from each treatment group were designated for FOB/MA/NP testing while another 10 males from each treatment group were utilized for SCOB testing. Control (0 ppm) and high-concentration groups contained an additional 10 animals (5 males and 5 females) for possible post-exposure/recovery evaluation. Exposures were conducted 6 hr/day, 5 days/wk for 65 exposures over 13 consecutive weeks for food-restricted animals assigned to the SCOB group. Ad-libitum-fed animals assigned to the FOB/MA/NP group were exposed for 65 exposures over 14 weeks; the extra week of exposures was required because animals were not exposed on days when the FOB and MA tests were conducted.
Animals exposed to 1500 or 3000 ppm (7.05 or 14.10 mg/L) had minimal to minor reduced activity levels only during exposure. At 3,000 ppm, increased motor activity using MA assessments was seen in some animals while decreased activity was observed in other animals. Although the mean was not significantly greater than controls, the standard deviation was significantly greater than in controls. However, there was no evidence of neurotoxicity observed using FOB testing, SCOB endpoints or neuropathological examinations. There was no evidence of a cumulative effect of exposure on the severity of reduced activity. There were no other apparent differences in the clinical condition of FOB/MA/NP and SCOB animals. Body weights and/or body weight gains were reduced in the 1500 and 3000 ppm (7.05 and 14.10 mg/L) male and female animals. No differences in body weight or rate of weight gain were noted in the 500 ppm (2.350 mg/L) exposure group animals when compared to control groups. Histopathological evaluations of animals from the control and 3000 ppm groups did not indicate any treatment related effects.
Read across justification to propan-1-ol and n-butyl acetate for filling data gaps of n-propyl acetate:
As indicated by toxicokinetic studies (see chapter on toxicokinetics, metabolism and distribution), n-propyl acetate is rapidly hydrolyzed to propan-1-ol and acetate (acetic acid). Available data on propan-1-ol is therefore suitable for filling data gaps of n-propyl acetate.
N-propyl acetate and n-butyl acetate differ structurally by only one βCH2 group and both substances have a similar toxicological profile. The available data for n-butyl acetate is therefore suitable for filling the data gaps of n-propyl acetate due to structural similarities. For a detailed justification of read-across, please refer to IUCLID section 13.
Justification for classification or non-classification
Taken together all available data for propyl acetate and analogous substances, there were no irreversible subchronic neurotoxic effects in doses without systemic toxicity. Therefore no classification is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1